Summer Special! Get NewsNow Essentials at just £2.49 a month (37% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £2.49 a month (37% OFF!). Subscribe and saveSummer Special! Upgrade here at £2.49/m (37% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Eli Lilly
Pharmaceuticals
Novo Nordisk
GSK
AstraZeneca
Merck and Co
Sanofi
Johnson and Johnson
Takeda
Pfizer
Bristol Myers Squibb
Teva
Topics

Advertisement

Eli Lilly

Share

Top Latest Popular

Why Eli Lilly (Lly) is a Top Momentum Stock for the Long-Term

Zacks 2d

GLP-1 demand is soaring. 2 Stocks that could benefit from this (hint: Not Eli Lilly or Novo Nordisk)

The Motley Fool 5d

Eli Lilly's GLP-1 pricing problem is actually a growth opportunity

The Motley Fool 6d

Advertisement

Advertisement

Eli Lilly is building a weight loss drug for every kind of patient

The Motley Fool 4d

Eli Lilly just scored Europe's first weight loss pill approval -- and the growth story keeps getting bigger

The Motley Fool 5d

Leal Therapeutics announces $30 million Series a extension and initiation of phase 1b/2a clinical trial of ltx-001 in schizophrenia

PR Newswire (Press Release) 2d

Advertisement

Advertisement

Advertisement

About our Eli Lilly news

Latest news on on Eli Lilly and Company, an American pharmaceutical with headquarters in Indianapolis.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis